SCHEMBL23918099

SCHEMBL23918099

c1ccc(N(c2ccccc2)c2ccc3c(c2)Sc2ccc(N(c4ccccc4)c4ccc5oc6ccccc6c5c4)cc2O3)cc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.36
MEN1 O00255 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
KMT2A Q03164 3/20 0.36
NPC1 O15118 2/20 0.36
KDM4E B2RXH2 2/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
AHR P35869 2/20 0.33
LMNA P02545 2/20 0.32
USP2 O75604 1/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPY5R Q15761 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23918102 0.94 AHR (0.35) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL23918052 0.84 MAPT (0.44) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL23918100 0.84 KDM4E (0.30) MAPTHPGDKDM4ETSHRHTT
SCHEMBL23918071 0.83
SCHEMBL22180377 0.82 GPR3 (0.33) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL15730657 0.81 MAPT (0.52) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL22180398 0.81 KDM4E (0.32) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL10042889 0.81 MAPT (0.52) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL23308823 0.81 MAPT (0.52) MAPTMEN1ALDH1A1HPGDKMT2A
SCHEMBL14295296 0.81 MAPT (0.52) MAPTMEN1ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR10J3, OCIAD1 MAPT 3115/4885MEN1 349/4885ALDH1A1 1148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.